Related by context. Frequent words. (Click for all words.) 58 histone deacetylase HDAC inhibitor 57 ALN TTR 55 2 methoxyestradiol 55 EP# [003] 55 triple VEGF receptor 55 proteasome inhibitor 55 CCR5 antagonist 54 Panzem R 54 refractory chronic lymphocytic 54 DB# [003] 54 targeting CD# 54 Drug Candidate 54 polymerase inhibitor 53 Factor VIIa 53 Meets Primary Endpoint 53 multi kinase inhibitor 53 EndoTAG TM -1 53 Aliskiren 53 novel orally administered 53 Panzem R NCD 53 Initiates Phase II 52 Monoclonal Antibody 52 selectively inhibits 52 REP# 52 humanized anti 52 Interferon alpha 52 EZN 52 chemokine receptor 52 ARX# [001] 52 Voreloxin 52 Receives Orphan Drug Designation 52 Polymorphism 52 GV# [001] 52 Lenalidomide 52 Tarvacin TM 52 poly ADP ribose polymerase 52 M Enoxaparin 52 liposomal formulation 52 SG# [003] 52 candidates bavituximab 52 Trofex 52 factor VIIa 52 SO DIMM 52 Ampligen ® 51 Hepatitis C Virus HCV 51 TLR9 agonist 51 KRN# 51 anticancer compound 51 immunomodulating 51 B lymphocyte stimulator 51 Shigamabs ® 51 Abstract Number 51 Anticalins 51 Tesetaxel 51 drug conjugates 51 Guanilib 51 histone deacetylase 51 nucleoside reverse transcriptase inhibitor 51 vascular disrupting agent 51 Nexavar ® 51 HCV protease inhibitor 51 Small Molecule 51 Study Evaluating 51 Gemzar ® 51 Daclizumab 51 Nephrol 50 peripherally acting 50 Ceftaroline 50 Moxifloxacin 50 selective inhibitor 50 active cellular immunotherapy 50 Patent Lawsuit 50 Affymetrix GeneChip 50 orally bioavailable 50 personalized immunotherapy 50 NS5A 50 mTOR inhibitor 50 Nanobody 50 Investigational Drug 50 ONX 50 humanized monoclonal antibody 50 MF# [002] 50 MEK inhibitor 50 Epidermal Growth Factor Receptor 50 Carfilzomib 50 JAK inhibitor 50 fusion inhibitor 50 AMD# [002] 50 immunostimulatory 50 Oritavancin 50 Preclinical Data 50 BAL# [001] 50 E# E# [002] 49 E# [005] 49 Alzhemed TM 49 AEGR 49 IND Investigational New 49 radiolabeled 49 AEG# 49 Antigens 49 SiTel